1 / 22

Short bowel syndrome

Short bowel syndrome. Dr. Henrik Csaba Horvath. Bible class February 20, 2013. Definition of short-bowel syndrome. Loss of intestinal absorption from surgical resection , congenital defect or diseases characterized by the inability to maintain

rosine
Download Presentation

Short bowel syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Short bowelsyndrome Dr. Henrik Csaba Horvath BibleclassFebruary 20, 2013

  2. Definition ofshort-bowelsyndrome Loss of intestinal absorptionfromsurgicalresection, congenitaldefectordiseasescharacterizedbytheinabilitytomaintain protein-energy, fluid, electrolyte, ormicronutrientbalanceswhen on a conventionallyaccepted, normal diet

  3. Whichconditionscanleadto a short-bowelsyndrome? c Physicallossof portionsofintestine Loss offunction Surgical resection (volvulus) Obstruction Disease-associated lossofabsorption (Crohn`s, postirradiation) Loss ofbowel orenterocyte mass (trauma, infarction) Dysmotility Congenital defect SBS-associated intestinal failure

  4. Major causesof SBS in adults? Postoperative complications Irradiaton/cancer Mesentericvalvulardisease (mesentericischemia) Crohn`sdisease Trauma

  5. Whichfactorsareassociatedwithworseprognosis in patientswithSBS? Total parenteral nutrition < 50 cm intactbowel Enterostomy Radiation orischemicenteritis

  6. Whichfactorshaveimpact on theoutcomeof SBS? Presence/abscenceofileocaecalvalve • Lengthofthe • remainingintestine • Segment ofintactbowel • (jejunum vs. ileum, coloncontinuity) • Absorptive qualityof • theremnantbowel Outcomeof SBS • Presence of residual • underlyingdisease • (e.g.Crohn`s) • State ofother digestive organs • Efficacyof • nutritionsupport • Pharmacologictherapy • Age/BMI of • thepatient

  7. Howdoesaffecttheremnantlengththeriskofdeveloping SBS? Patientsathighestriskofdeveloping SBS are

  8. Whichimpacthas on absorptiontheresectionof… Loss ofthemajor intestinal absorptionarea Loss of digestive enzymes Loss of GI feedbackhormones (gastricemptying) Jejunum: Ileum: Loss oftheabsorptionofjejunalsecretion Loss ofabsorptionofvitamin B12 Loss ofabsorptionofbilesalts (fatmalabsorption)

  9. Whichimpacthasthelossofileocaecalvalve? Dilatation ofthesmallintestine Slowermotility Bacterialovergrowthofthe small intestine Competitionfornutrients, inflammation, GI bleeding, bacterialtranslocation± endotoxaemia, liverinjury, D-lacticacidosis

  10. Which adaptive mechanismsoccur in the residual intestine/ GI tract? Mucosalhyperplasia (due tofatstimulatedglucagon-likepeptidereceptor II) Increasedmucosalbloodflow Improved segmental absorption Gastrichypersecretion Increasedpancreatobiliarysecretions • Upto 70% can do without TPN due tothesemechanisms

  11. Importanceofcolonin compensationforthe lack ofintestine? Increasereabsorptionofwater, electrolytes, short-chainfattyacidsand GI secretions Slow down the intestinal transitandstimulate intestinal adaptationby hormonal regulation Fermentation ofmalabsorbedcarbohydratesbycolonicbacteria

  12. Measurement ofthefunctionalcapacityofthesmallintestine? 1. 48-hour nutritional balancetest analysisofdailyabsorption rate (intake-output) predictionof intestinal failure: <1,4 kg wetweight/day 1170 kcal/dayofenergy (Difficultieswithduplicatefoodportionsandaccuratestoolcollections) 2. Fastingplasmacitrullineconcentration (>5 μmol/L) (issynthetizedbythesmallintestine, bestpracticalmeasureofenterocytefunction)

  13. Twomajorgroupsofcomplicationsof SBS? dehydration electrolytederangements (Mg, Ca, K) • Early complications: Diagnosis: • urinaryelectrolytelevels (plasmacanbe normal!) Treatment: • sustainedcorrection due toslowcellularuptake • Latecomplications: TPN-related bacterialovergrowth micronutrientdeficiency metabolic

  14. TPN-relatedlatecomplicationsof SBS are… gallstones, cirrhosis(IFALD) 1. Due tobypassfirst pass livermetabolism: steatosis cholestasis end-stagelivercirrhosis in 15% ofpts after oneyear TPN 100% mortality rate within 2 yrs • 2. Catheter-associatedcomplications: infection: one-thirdofdeaths in 50% 5-yr-mortality rate in SBSthrombosis (v. cavasuperior): 0.2/1000 catheterdays

  15. Bacterialovergrowth-relatedlatecomplicationsof SBS are… 1. carbohydratemalabsorption 2. sepsis due tobacteriallocalisation 3. decreasedabsorptionoffattyacids due tointerferencewithchilomicronformation 4. lossof absorptive capacity due toinflammatoryresponse

  16. Whicharethemostcommonmicronutritientdeficienciesaslatecomplicationsof SBS? 1. Mg, Ca, Zn, Se 2. fat-soluble vitamins (A,D,E,K) 3.vitamin B12 (if >60 cm of terminalileumresected) 4. folate (if proximal jejunumresected)

  17. The mostcommonmetaboliccomplicationsofsmall-bowelsyndrome? Metabolicacidosis Hyperoxaliuria (nephrolithiasis, chronicrenalfailure) Hyperammoniaemia Metabolicbonedisease (osteoporosis, osteomalacia) gram-positive colonicbacteria fermentcarbohydrateto D-lacticacid proliferationoftheflora Acidicenvironment short-chainfattyacids Metabolicacidosis(encephalopathy, headaches, ataxia, dysarthria)

  18. 3 keypointsofmanagement? • Nutrition / Supplementation ofmicronutrients • Maintaining fluid, electrolytesandacid/basebalance • Avoidcomplications Caloriestobesupplied: Proteins tobesupplied: 1.0-1.5 g/kg/day 25-30 kcal/kg/day 40-50% carbohydrates 20-30% proteins 20-40% lipids Bolus enteral Continous enteral Cyclic/discontinous PN Oral rehidrationfluid (glucose-polymer basedwithsodium) ORS ± oral electrolytesuppl. Intravenous fluid Continous PN

  19. Pharmacologicadjuncts in themanagement? 1. glucagon-like peptide-2 (teglutide): promotionofadaption 2. loperamid, diphenoxylate, codein: anti-motilityagents • 3.octreotid: increasingthesmallboweltransittime (but also inhibitspancreaticsecretions) onlyif > 3 L ofiv. fluid intakeisrequired • 4. cholestyramine: bindingbilesaltsin steatorrheasecondarytobileacidmalabsorption Cheng TT et al :Clinical and Experimental Gastroenterology 2011:4 189–196

  20. Twocategoriesofsurgicaltreatmentoptions? 2. transplant 1. non- transplant Aimsof non-transplant surgicaltreatments? Preserve intestinal remnant minimizeresrection, restore intestinal continuity, recruit additional intestine 2. Slow intestinal transit (segmental reversalofintestine, colonicinterposition) 3. Increase intestinal surface (LILT = longitudinal intestinal lengtheningandtailoring withlongitudinal devisionofintestineandbloodsupplyatthemesentericborder) STEP = serialtransverseenteroplasty)

  21. Surgicaltreatmentofshortbowelsyndrome Indicationsfor intestinal transplants? Impendingorovertliverfailure (ESLD) Thrombosisofmajorcentralvenouschannels Frequentcentralline-relatedsepsis (>2 episodes/year) Frequentseveredehydration Diffuse mesentericvenousthrombosiswithcomplications

  22. Intestinal transplantationfor SBS Whicheffecthasthecombined transplant on therejection rate of intestinal transplants? Acuteandchronicrejection rate islower in combinedtransplants (liver+intestine, multivisceral) Major complicationsandcauseofdeath after intestinal transplantation? Sepsis, MOF, rejection

More Related